TABLE 3.
Regression Slope (±SE) of the Risk Factor Change in the Treatment Group (Dependent Variable) vs. Cumulative Number of Food Records Entered per Week (Independent Variable, a Measure of Compliance)
| Slope ± SE | Significance | |||||
| Δ3 months | Δ6 months | Δ12 months | Δ3 months | Δ6 months | Δ12 months | |
| Sample size (treatment/control) | 87 | 81 | 66 | |||
| ΔBMI (kg/m2) | −0.26 ± 0.07 | −0.30 ± 0.09 | −0.37 ± 0.10 | 0.0008 | 0.0009 | 0.0005 |
| ΔWeight (kg) | −0.75 ± 0.21 | −0.95 ± 0.27 | −1.16 ± 0.32 | 0.0004 | 0.0007 | 0.0005 |
| ΔBodyfat (%) | −0.42 ± 0.15 | −0.52 ± 0.20 | −0.79 ± 0.21 | 0.005 | 0.01 | 0.0005 |
| ΔWaist circumference (cm) | −0.49 ± 0.28 | −0.94 ± 0.29 | −1.03 ± 0.31 | 0.09 | 0.002 | 0.001 |
| ΔHip circumference (cm) | −0.28 ± 0.31 | −0.24 ± 0.32 | −0.53 ± 0.32 | 0.37 | 0.45 | 0.10 |
| ΔSystolic blood pressure (mmHg) | −1.01 ± 0.50 | −1.28 ± 0.67 | −0.26 ± 0.74 | 0.05 | 0.06 | 0.73 |
| ΔDiastolic blood pressure (mmHg) | −0.35 ± 0.41 | −0.72 ± 0.52 | −0.73 ± 0.57 | 0.39 | 0.17 | 0.20 |
| ΔHeart rate (bpm) | −0.74 ± 0.48 | −1.26 ± 0.44 | −1.08 ± 0.58 | 0.13 | 0.006 | 0.07 |
| ΔTotal cholesterol (mg/dL) | 0.02 ± 1.21 | −0.85 ± 1.37 | −2.34 ± 1.59 | 0.99 | 0.54 | 0.15 |
| ΔTriglycerides (mg/dL) | −4.53 ± 3.27 | −13.54 ± 4.78 | −6.44 ± 4.98 | 0.17 | 0.006 | 0.20 |
| ΔLog triglycerides (mg/dL) | −0.01 ± 0.02 | −0.07 ± 0.02 | −0.03 ± 0.03 | 0.53 | 0.004 | 0.21 |
| ΔHDL-cholesterol (mg/dL) | 0.46 ± 0.38 | 0.88 ± 0.40 | 0.48 ± 0.38 | 0.23 | 0.03 | 0.21 |
| ΔLDL-cholesterol (mg/dL) | −0.33 ± 1.04 | 0.29 ± 1.14 | −1.94 ± 1.47 | 0.75 | 0.80 | 0.19 |
| ΔVLDL-cholesterol (mg/dL) | −0.15 ± 0.50 | −2.13 ± 0.73 | −0.99 ± 0.81 | 0.77 | 0.005 | 0.22 |
| ΔLog VLDL-cholesterol (mg/dL) | 0.00 ± 0.02 | −0.08 ± 0.03 | −0.06 ± 0.03 | 0.93 | 0.003 | 0.09 |
| ΔVLDL/Triglyceride | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.91 | 0.47 | 0.31 |
| ΔTotal cholesterol/HDL | −0.06 ± 0.04 | −0.12 ± 0.04 | −0.10 ± 0.05 | 0.10 | 0.004 | 0.07 |
| ΔHDL/Triglyceride | 0.00 ± 0.01 | 0.03 ± 0.01 | 0.01 ± 0.01 | 0.85 | 0.01 | 0.43 |
| ΔApo A1 (mg/dL) | 0.53 ± 0.89 | 0.27 ± 1.05 | −0.13 ± 0.93 | 0.55 | 0.80 | 0.89 |
| ΔSmall dense LDL (mg/dL) | −0.71 ± 0.60 | −1.00 ± 0.63 | −1.57 ± 0.88 | 0.24 | 0.11 | 0.08 |
| ΔHDL-map (mg/dL of Apo-A1) | ||||||
| α1 | 0.67 ± 0.31 | 0.92 ± 0.34 | 0.70 ± 0.30 | 0.03 | 0.009 | 0.03 |
| α2 | 0.45 ± 0.48 | 0.69 ± 0.59 | 0.67 ± 0.52 | 0.36 | 0.25 | 0.20 |
| α3 | −0.33 ± 0.25 | −0.59 ± 0.26 | −0.44 ± 0.31 | 0.19 | 0.02 | 0.17 |
| α4 | −0.15 ± 0.23 | −0.51 ± 0.25 | −0.66 ± 0.27 | 0.53 | 0.05 | 0.02 |
| preβ1 | −0.20 ± 0.21 | −0.30 ± 0.18 | −0.13 ± 0.24 | 0.33 | 0.09 | 0.58 |
| ΔCRP | −0.03 ± 0.08 | −0.07 ± 0.09 | −0.09 ± 0.09 | 0.69 | 0.44 | 0.32 |
| ΔAdiponectin | 0.04 ± 0.07 | 0.12 ± 0.08 | 0.22 ± 0.08 | 0.52 | 0.12 | 0.01 |
| ΔFasting Glucose (mg/dL) | −0.50 ± 0.47 | −0.92 ± 0.57 | −0.88 ± 0.81 | 0.29 | 0.11 | 0.28 |
| ΔFasting Insulin (μU/mL) | −1.18 ± 0.58 | −1.27 ± 0.70 | −0.47 ± 0.91 | 0.05 | 0.08 | 0.60 |
| ΔHOMA-IR | −0.46 ± 0.28 | −0.37 ± 0.21 | −0.16 ± 0.27 | 0.10 | 0.08 | 0.55 |
| ΔHbA1c (%) | −0.01 ± 0.01 | −0.04 ± 0.01 | −0.03 ± 0.01 | 0.28 | 0.002 | 0.09 |
| ΔGlycated serum protein (μg/mL) | 0.27 ± 1.43 | 1.92 ± 1.99 | 1.56 ± 2.62 | 0.85 | 0.34 | 0.55 |